Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the RespimatÂ® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I